Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (32)
NITAG documentation (1597)
Reports (56)
SAGE documentation (226)
Scientific publications (112)
Systematic reviews (SYSVAC) (2883)
Regions
Africa (278)
Americas (768)
Eastern Mediterranean (50)
Europe (708)
South-East Asia (81)
Western Pacific (207)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1523)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (159)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (72)
HIV / AIDS (10)
Human papillomavirus (HPV) (497)
Influenza (589)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (133)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (107)
Pneumococcal disease (281)
Poliomyelitis (86)
Q fever (1)
Rabies (30)
Rotavirus (117)
RSV (Respiratory syncytial virus) (52)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (78)
Typhoid (25)
Varicella (73)
Yellow fever (42)
Zika (1)
Show more
4906 results found
2026
Optimization tool
2025
∙
SAGE
WHO guidance on the use of licensed human influenza A(H5) vaccines for the interpandemic and emergence periods
2025
∙
ATAGI
ATAGI statement: Counterfeit Rabies vaccine (Abhayrab®) reported in India: Guidance for travellers and healthcare providers
2025
∙
ATAGI
ATAGI statement on the importance and safety of Hepatitis B vaccine at birth
2025
∙
Ndzouboukou, J. L. B. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.
A Meta-Analysis on the Immunogenicity of Homologous versus Heterologous Immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA.1 VoCs in Healthy Adults
2025
∙
Banga Ndzouboukou, J. L. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.
A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults
2025
∙
Vittrup, D. M. Charabi, S. Jensen, A. Stensballe, L. G.
A systematic review and meta-analysis of adverse events following measles-containing vaccines in infants less than 12 months of age
2025
∙
Kitano, T. Salmon, D. A. Dudley, M. Z. Saldanha, I. J. Thompson, D. A. Engineer, L.
A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions
2025
∙
Gebreal, A. Ashmawy, R. Ahmed, M. J. Khattab, M. Shata, K. S. Elmansoury, A. Estifanos, H. Eissa, M. H. Ahmed, W. Hasan, H. M. Mahmutaj, A. Abourady, Y. El Arab, L. E. Abass, M. Adhyaru, R. Ghazy, R. M.
A systematic review and meta-analysis on parental uptake and willingness to vaccinate children against human papillomavirus in the Eastern Mediterranean Region
2025
∙
Pow, J. Clarke, L. McHale, S. Gray-Brunton, C.
A systematic review and thematic synthesis exploring how gay, bisexual and other men who have sex with men (GBMSM) experience HPV and HPV vaccination
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register